loader image
Close
HYPharm_logoHYPharm_logoHYpharm_Logo-mobileHYPharm_logo
  • About Us
  • Technology
  • Applications
  • Cooperation
  • News
Contact
✕
28. Februar 2025

Meet HYpharm next week at the @AMR Conference in Basel!

Read More
27. Februar 2025

Our designer molecule HY-133 is on TV!

Read More
26. Februar 2025

Parlamentskreis gegen Antimikrobielle Resistenzen gegründet

Read More
25. Februar 2025

Phagenlysin-Wirkstoff HY-133: Start der klinischen Phase-I-„First-in-Human“-Studie zur Eliminierung von Staphylococcus aureus im Nasenmikrobiom

Read More
24. Februar 2025

Infektiolog:innen fordern Investitionen in Forschung, Entwicklung und den verantwortungsvollen Einsatz von Antibiotika

Read More
11. Juni 2024

Innovative Phage Lysin HY-133 enters phase I clinical study

Read More
29. Februar 2024

8th AMR Conference

Read More
29. Februar 2024

WAAW23 Fighting Staphylococcus aureus with HY-133

Read More
22. November 2022

Every year, more than 11 million people die from a #Sepsis.

Read More
6. Oktober 2022

Infection prevention by fostering prevention methods

Read More
© 2025 HYpharm
  • Privacy statement
  • Imprint
Contact
    This website uses cookies. If you continue to use the website, we assume your consent.OKDatenschutzerklärung